Thank you all for the valuable input.
So, based on the assumptions:
- Animal testing complete in October
- Bench testing has been ongoing for multiple years, its completion does not post date the completion of animal testing.
- IDE submission in November
It seems unlikely that Pivotal Study approval could occur prior to the new year.
New 6-month low, or 24-month low?, page-60
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.35 |
Change
0.150(0.87%) |
Mkt cap ! $333.5M | |||
| Open | High | Low | Value | Volume |
| $17.19 | $17.39 | $16.90 | $350.7K | 20.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 66 | $17.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |